Skip to main content

Table 1 Association of CHD1L protein expression with clinic-pathological parameter

From: CHD1L Protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival

   CHD1L protein expression
Variable Allcase negative positive P Valuea
Age at surgery (years)     0.168
 ≤ 51 b 54 23(52.6%) 31(57.4%)  
 > 51 48 27(56.2%) 21(43.8%)  
Histological type     
 Serous 72 35(48.6%) 37(51.4%) 0.029
 Mucinous 11 9(81.8%) 2(18.2%)  
 Othersc 19 6(32.6%) 13(68.4%)  
Histologicalgrade(Silveberg)     0.745
 G1 16 9(56.2%) 7(43.8%)  
 G2 61 30(48.2%) 31(50.8%)  
 G3 25 11(44.0%) 14(56.0%)  
FIGO stage     0.354
 I 19 8(42.1%) 11(57.9%)  
 II 10 7(70.0%) 3(30.0%)  
 III 58 26(44.8%) 32(55.2%)  
 IV 15 9(60.0%) 6(40.0%)  
Residual tumor     0.469
 None 32 15(46.9%) 17(53.1%)  
 <=2cm 35 15(42.9%) 20(57.1%)  
 >2cm 35 20(47.1%) 15(42.9%)  
  1. aChi-square test.
  2. b Mean age.
  3. cEndometrioid, Clear cell and Undifferentiated types.